Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01968772 · ClinicalTrials.gov registry record · NA
Effect of Transdermal Magnesium Chloride on Quality of Life in Patients With Fibromyalgia
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT01968772: Completed NA study, sponsored by Mayo Clinic.
NCT01968772 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 40 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01968772, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
In this pilot study we propose to gather preliminary data on whether transdermal magnesium chloride can improve quality of life in patients with fibromyalgia. Forty women with fibromyalgia will be enrolled in this study. Participants will be asked to apply a topical solution of magnesium chloride on their extremities 3 times daily for 28 consecutive days. Three questionnaires measuring quality of life will be administered at baseline, at 2 weeks, and at 4 weeks (end of study).
Interventions
- OTHER Transdermal Magnesium Chloride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2013-10 |
| Est. Completion | 2014-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01968772
The ClinicalTrials.gov registry entry for NCT01968772 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Transdermal Magnesium Chloride is the first listed.
NCT01968772 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01968772 about?
NCT01968772 is a clinical study titled "Effect of Transdermal Magnesium Chloride on Quality of Life in Patients With Fibromyalgia". In this pilot study we propose to gather preliminary data on whether transdermal magnesium chloride can improve quality of life in patients with fibromyalgia. Forty women with fibromyalgia will be enrolled in this study. Participants will be asked to apply a topical solution of magnesium chloride on...
What is the current status of trial NCT01968772?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2013-10. Estimated completion is 2014-09.
What interventions are being tested in trial NCT01968772?
The interventions under investigation include: Transdermal Magnesium Chloride (OTHER).
Who is sponsoring clinical trial NCT01968772?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.